Minia UNiversity hospital
Minya, Minya Governorate, 61111, Egypt
NCT Number: NCT04139811
Internal limiting membrane peeling is performed during vitrectomy for macular diseases such as macular holes, macular edema due to diabetic retinopathy and retinal vein occlusion.
The incidence of epiretinal membrane formation after vitrectomy for rhegmatogenous detachment has been reported to range from 4.4% to 12.8%.
In this study, the efficacy and safety of internal limiting membrane peeling will be studied in vitrectomy for rhegmatogenous retinal detachment and if it is essential to peel it in those cases or not.
Looking for future studies?
Notify Me20 year–73 year
All sexes
Interventional
Not applicable
Minya, Minya Governorate, 61111, Egypt
interventional observational study comparing vitrectomy with versus without internal limiting membrane peeling in cases of rhegmatogenous retinal detachment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vitrectomy with and without ILM peeling
Time frame: 6 months follow up
Rate of retinal reattachment using indirect ophthalmoscopy
Time frame: 6 months follow up
incidence rate of epiretinal membrane formation after surgery in % percent
Time frame: 6 months follow up
visual functions using log Mar Best Corrected Visual Acuity (BCVA)
Time frame: 6 months follow up
measurement of percent (%) of superficial and deep capillary density using Optical Coherance Tomography Angiography
Time frame: 6 months follow up
measurement of P1 amplitude
Minia University
Other
Evaluation of Primary Internal Limiting Membrane Peeling in Cases of Rhegmatogenous Retinal Detachment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04676256
Eye Diseases, Retinal Break
Paris, Île-de-France Region, France
View Trial DetailsNCT01767038
Eye Diseases, Retinal Detachment
Besançon, France
View Trial DetailsNCT07058337
Eye Diseases, Retinal Detachment
Cairo, Egypt
View Trial DetailsNCT03479736
Achilles Tendon, Acute Aortic Syndrome
Titusville, New Jersey, United States
View Trial Details